# Development of a Device for Evaluating Primary Hemostasis Under Whole Blood Flow Conditions

> **NCT03773159** · — · RECRUITING · sponsor: **Centre Hospitalier Universitaire Dijon** · enrollment: 200 (estimated)

## Conditions studied

- Von Willebrand Diseases
- Major Constitutional Thrombopathy
- Patient on Antiplatelet Drugs

## Interventions

- **BIOLOGICAL:** Blood sampling

## Key facts

- **NCT ID:** NCT03773159
- **Lead sponsor:** Centre Hospitalier Universitaire Dijon
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2019-05-06
- **Primary completion:** 2028-05
- **Final completion:** 2028-05
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03773159

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03773159, "Development of a Device for Evaluating Primary Hemostasis Under Whole Blood Flow Conditions". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03773159. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*